1. Home
  2. IVA vs MOND Comparison

IVA vs MOND Comparison

Compare IVA & MOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • MOND
  • Stock Information
  • Founded
  • IVA 2011
  • MOND 2011
  • Country
  • IVA France
  • MOND United States
  • Employees
  • IVA N/A
  • MOND N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • MOND Transportation Services
  • Sector
  • IVA Health Care
  • MOND Consumer Discretionary
  • Exchange
  • IVA Nasdaq
  • MOND Nasdaq
  • Market Cap
  • IVA 117.3M
  • MOND 109.3M
  • IPO Year
  • IVA 2020
  • MOND N/A
  • Fundamental
  • Price
  • IVA $2.73
  • MOND $1.26
  • Analyst Decision
  • IVA Strong Buy
  • MOND Buy
  • Analyst Count
  • IVA 3
  • MOND 4
  • Target Price
  • IVA $17.67
  • MOND $3.63
  • AVG Volume (30 Days)
  • IVA 634.3K
  • MOND 93.7K
  • Earning Date
  • IVA 09-25-2024
  • MOND 11-12-2024
  • Dividend Yield
  • IVA N/A
  • MOND N/A
  • EPS Growth
  • IVA N/A
  • MOND N/A
  • EPS
  • IVA N/A
  • MOND N/A
  • Revenue
  • IVA $20,652,523.00
  • MOND $232,972,000.00
  • Revenue This Year
  • IVA N/A
  • MOND $11.81
  • Revenue Next Year
  • IVA $469.85
  • MOND $15.08
  • P/E Ratio
  • IVA N/A
  • MOND N/A
  • Revenue Growth
  • IVA N/A
  • MOND 28.39
  • 52 Week Low
  • IVA $1.53
  • MOND $1.10
  • 52 Week High
  • IVA $4.75
  • MOND $4.69
  • Technical
  • Relative Strength Index (RSI)
  • IVA 67.19
  • MOND 45.55
  • Support Level
  • IVA $2.19
  • MOND $1.10
  • Resistance Level
  • IVA $2.85
  • MOND $1.37
  • Average True Range (ATR)
  • IVA 0.18
  • MOND 0.08
  • MACD
  • IVA 0.11
  • MOND 0.04
  • Stochastic Oscillator
  • IVA 90.40
  • MOND 76.63

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About MOND Mondee Holdings Inc.

Mondee Holdings Inc is a travel technology company & marketplace with a portfolio of leisure & corporate travel sectors. The company provides AI platforms, technologies, operating systems, & services that enable travel transactions to serve travelers directly or through travel affiliates. The company has two segments Travel Marketplace & SAAS Platform. The Travel Marketplace segment consists of selling airline tickets through the proprietary platform. The SAAS Platform segment offers corporate travel cost savings solutions through its technology platform. The majority is from the Travel Marketplace segment. Geographically, the key revenue is from the United States.

Share on Social Networks: